A Look Into Healthcare Sector Value Stocks
A Look Into Healthcare Sector Value Stocks
What Defines a Value Stock?
價值股票的定義是什麼？
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
傳統上，價值股的定義是市場上投資者如何估值該公司的未來增長前景。低市盈倍數是很好的基本指標，表明該公司的估值被低估，很可能被標記爲價值股。
Below is a list of notable value stocks in the healthcare sector:
以下是醫療保健領域值得注意的價值股票清單：
- Exicure (NASDAQ:XCUR) - P/E: 0.33
- Kiora Pharmaceuticals (NASDAQ:KPRX) - P/E: 0.69
- BioNTech (NASDAQ:BNTX) - P/E: 8.4
- TherapeuticsMD (NASDAQ:TXMD) - P/E: 0.49
- Viatris (NASDAQ:VTRS) - P/E: 7.05
- Exicure（納斯達克股票代碼：XCUR）-市盈率：0.33
- Kiora Pharmicals（納斯達克股票代碼：KPRX）-市盈率：0.69
- BioNTech（納斯達克股票代碼：BNTX）-市盈率：8.4
- TherapeuticSMD（納斯達克股票代碼：TXMD）-市盈率：0.49
- Viatris（納斯達克股票代碼：VTRS）-市盈率：7.05
This quarter, Exicure experienced an increase in earnings per share, which was $-0.7 in Q1 and is now $-0.68. Most recently, Kiora Pharmaceuticals reported earnings per share at $-0.89, whereas in Q2 earnings per share sat at $-0.79. Most recently, BioNTech reported earnings per share at $0.73, whereas in Q2 earnings per share sat at $-0.86. Most recently, TherapeuticsMD reported earnings per share at $-0.13, whereas in Q2 earnings per share sat at $-0.24. Viatris has reported Q3 earnings per share at $0.79, which has increased by 5.05% compared to Q2, which was 0.75. Most recently, the company reported a dividend yield of 5.18%, which has increased by 0.59% from last quarter's yield of 4.59%.
本季度，Exicure的每股收益有所增加，第一季度爲-0.7美元，現在爲-0.68美元。最近，Kiora Pharmicals公佈的每股收益爲-0.89美元，而第二季度每股收益爲-0.79美元。最近，BioNTech公佈的每股收益爲0.73美元，而第二季度每股收益爲-0.86美元。最近，TherapeuticSMD公佈的每股收益爲-0.13美元，而第二季度每股收益爲-0.24美元。Viatris公佈的第三季度每股收益爲0.79美元，與第二季度的0.75美元相比增長了5.05％。最近，該公司公佈的股息收益率爲5.18％，較上個季度的4.59％增長了0.59％。
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
這5只價值股是Benzinga Insights根據量化分析選擇的。儘管這種有條理的判斷過程並不意味着做出最終決定，但我們的技術可以讓投資者對該行業有更多的認識。
譯文內容由第三人軟體翻譯。